Cardinal Health Inc. (CAH)
Why Cardinal Health (CAH) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cardinal Health to Report Q2 Earnings: What's in Store for the Stock?
Despite recent supply-chain challenges, new facilities and growth in branded and specialty pharmaceutical sales are likely to have driven CAH's performance in the fiscal second quarter.
Cardinal Health (CAH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
Here is how Cardinal Health (CAH) and AIM ImmunoTech Inc. (AIM) have performed compared to their sector so far this year.
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cardinal Health Stock May Gain With New Texas Distribution Center
CAH announces the ongoing construction of a new distribution center in Texas, which is likely to support its at-Home Solutions business.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Cardinal Health (CAH) Increases Yet Falls Behind Market: What Investors Need to Know
In the latest trading session, Cardinal Health (CAH) closed at $124.71, marking a +0.55% move from the previous day.
Cardinal Health, Inc. (CAH) CEO Jason Hollar presents at J.P. Morgan Healthcare Conference (Transcript)
Cardinal Health, Inc. (NYSE:CAH ) J.P. Morgan Healthcare Conference January 14, 2025 12:00 PM ET Company Participants Aaron Alt - CFO Jason Hollar - CEO Conference Call Participants Lisa Gill - JPMorgan Lisa Gill Good morning.
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cardinal Health forecasts annual profit at higher end of prior range
Cardinal Health said on Tuesday it expects annual profit to be at the higher end of its previous forecast range, primarily driven by strong demand for costly specialty medicines and branded drugs at its pharmaceuticals unit.
